Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 02 Sept 2026 for BIOMERIEUX. Read the official filing
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
2
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Since each purchase
- +18.0%Entry €74.25 · Close 15 Oct 2026 €87.60
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jennifer Zinn: trading record in brief
Jennifer Zinn, listed as senior executive, appears in our data through filings on Biomerieux shares, published by AMF. We count 3 filings; the first trade dates from 27 June 2025 and the latest from 31 August 2026.
The open-market record is one-sided, with 2 purchases and not one sale. No amount is published for 2 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2026, the count stands at 2 purchases and no sales.
The latest filing, published on 2 September 2026, reports an open-market purchase in Biomerieux. Filings reach the AMF feed a median of 2 days after the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades. Source: insider filings from AMF. Past trades are no guide to future returns.
Companies and markets linked to Jennifer Zinn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
2,491 shares0Actions gratuitesHors plateforme de négociationISIN FR00132802862026DD1135780
Canonical exit: 29 Nov 2026 (T+90)
7,588 shares0Actions gratuitesHors plateforme de négociationISIN FR00132802862026DD1135781
Canonical exit: 29 Nov 2026 (T+90)
100 shares@ €104.48100.0% of flowActionEuronext ParisISIN FR00132802862025DD1047028
3 of 3 declarations
